Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins

被引：55
|
作者：
Alonso-de Castro, Silvia [2 ]
Cortajarena, Aitziber L. [2 ,3 ]
Lopez-Gallego, Fernando [2 ,4 ]
Salassa, Luca [1 ,3 ]
机构：
[1] Donostia Int Phys Ctr, Paseo Manuel de Lardizabal 4, Donostia San Sebastian 20018, Spain
[2] CIC biomaGUNE, Paseo Miramon 182, Donostia San Sebastian 20014, Spain
[3] Basque Fdn Sci, Ikerbasque, Bilbao 48011, Spain
[4] ARAID Fdn, Zaragoza, Spain
来源：
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2018年 / 57卷 / 12期
基金：
欧洲研究理事会;
关键词：
bioorthogonal chemistry; flavoproteins; metal-based prodrugs; photocatalysis; photochemotherapy; DNA-BINDING; OXYGEN; AGENTS; CELLS; GENERATION; REDUCTION; CHEMISTRY; MECHANISM; DELIVERY;
D O I：
10.1002/anie.201800288
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Recent advances in bioorthogonal catalysis promise to deliver new chemical tools for performing chemoselective transformations in complex biological environments. Herein, we report how FAD (flavin adenine dinucleotide), FMN (flavin mononucleotide), and four flavoproteins act as unconventional photocatalysts capable of converting Pt-IV and Ru-II complexes into potentially toxic Pt-II or Ru-II-OH2 species. In the presence of electron donors and low doses of visible light, the flavoproteins mini singlet oxygen generator (miniSOG) and NADH oxidase (NOX) catalytically activate Pt-IV prodrugs with bioorthogonal selectivity. In the presence of NADH, NOX catalyzes Pt-IV activation in the dark as well, indicating for the first time that flavoenzymes may contribute to initiating the activity of Pt-IV chemotherapeutic agents.
引用
收藏
页码：3143 / 3147
页数：5
相关论文
共 50 条
  • [1] Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs
    Mazzei, Laura F.
    Gurruchaga-Pereda, Juan
    Martinez, Alvaro
    Martinez, Javier Calvo
    Salassa, Luca
    Cortajarena, Aitziber L.
    [J]. CHEMICAL COMMUNICATIONS, 2023, 59 (32) : 4754 - 4757
  • [2] The development of ruthenium complexes as anticancer drugs activation and anticancer mechanism
    Liu, J
    Ji, LN
    Mei, WJ
    [J]. PROGRESS IN CHEMISTRY, 2004, 16 (06) : 969 - 974
  • [3] Activation of anticancer platinum complexes by tumoral acidity
    Meelich, K.
    Galanski, W.
    Arion, V. B.
    Jakupec, M. A.
    Schluga, P.
    Hartinger, C. G.
    Graf, v. Keyserlingk N.
    Keppler, B. K.
    [J]. METAL IONS IN BIOLOGY AND MEDICINE, VOL 9, 2006, 9 : 52 - +
  • [4] NOVEL CATALYTIC REACTIONS USING RUTHENIUM AND PLATINUM COMPLEXES
    WATANABE, Y
    MITSUDO, T
    TSUJI, Y
    [J]. JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1988, 46 (08) : 789 - 800
  • [5] Activation of organic compounds and catalytic reactions with ruthenium complexes
    Kawano, H
    Hiraki, K
    [J]. JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1996, 54 (04) : 256 - 266
  • [6] GLUTATHIONE-MEDIATED ACTIVATION OF ANTICANCER PLATINUM(IV) COMPLEXES
    EASTMAN, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (23) : 4177 - 4178
  • [7] Anticancer activity of heterodinuclear ruthenium(II)-platinum(II) complexes as photochemotherapeutic agents
    Yano, Takakazu
    Hishida, Shota
    Nakai, Misaki
    Nakabayashi, Yasuo
    [J]. INORGANICA CHIMICA ACTA, 2017, 454 : 162 - 170
  • [8] CATALYTIC ACTIVATION OF MOLECULAR HYDROGEN BY RUTHENIUM (III) CHLORIDE COMPLEXES
    HARROD, JF
    HALPERN, J
    CICCONE, S
    [J]. CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1961, 39 (06): : 1372 - &
  • [9] Ruthenium complexes as anticancer agents
    Kostova, I
    [J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (09) : 1085 - 1107
  • [10] Ruthenium and platinum antitumor complexes and their activation with 980-nm light
    Ruggiero, Emmanuel
    Salassa, Luca
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
12345